Bain Capital-backed Emcure Pharmaceuticals filed preliminary papers with capital markets regulator SEBI to raise funds through an initial share sale.

The initial public offering comprises fresh issuance of equity shares worth ₹1,100 crore and an offer of sale of over 1.8 crore (1,81,68,356) shares by promoters and existing shareholders, according to the draft red herring prospectus (DRHP).
https://www.thehindubusinessline.com/companies/emcure-pharmaceutica...